WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

WeightWatchers will begin selling compounded alternatives to certain weight-loss drugs that are experiencing shortages. Why ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

WeightWatchers recently announced the inclusion of compounded semaglutide into its suite of offerings. This new clinical weight management intervention aims to broaden access for eligible members who ...